JD Health (06618.HK) announced that the company will hold a board meeting on Tuesday, August 23, 2022 to, among other things, approve the unaudited interim results of the company and its subsidiaries for the six months ended June 30, 2022 and their announcements, and consider recommending the payment of an interim dividend (if any).
Management will hold a conference call at 09:30 (Beijing ╱ Hong Kong time) on Wednesday, August 24, 2022 to discuss the interim results of the Company and its subsidiaries for the six months ended June 30, 2022.